ASH Abstracts

Overview of our congress contributions

We see it as our central task to make our knowledge, data and results available for discussion and to the community through lectures, education and publications. Through international networking with other diagnostic laboratories and research groups worldwide, we work on a variety of scientific topics in hematology. In addition to international publications in peer-reviewed journals, many of our research results are presented at the annual ASH Congress (American Society of Hematology – Annual Meeting and Exposition).

Graphic of the papers presented at the ASH conference by year
2022
2024 2023 2022 2021 2020 2019
2024

Proteolytic Control and Therapeutic Targeting of Oncogenic Gene Expression in Acute Myeloid Leukemia

Uni M, Steinberg AP, Slavit A, Rha S1, Cheng S, Schmalbrock LK, Su J, Ma J, McPherson A, Mullighan CG, Haferlach T, Iacobucci I, Klco JM, Rabadan R, Kentsis A. Proteolytic Control and Therapeutic Targeting of Oncogenic Gene Expression in Acute Myeloid Leukemia. (#4149).

Assessment of the IPSS-M in Chronic Myelomonocytic Leukemia

Palomo L, Morgades M, Meggendorfer M, Díaz-Beyá M, Pomares H, López GR, Ibañez M, Tormo M, Lopez F, Pita, Caballero JC, Bou JV, Restrepo J, Roldan V, Galán P, Velasco EC, Notario C, Garcia Feria A, Haferlach T, Castaño-Díez S, MD4*, Alonso E, Pratcorona M, Collado R, Calabuig M, Acha P, Aguilar-Monserrate G, Cabezón M, Ruiz Xiville N, Diez-Campelo M, Zamora L, Xicoy B. Assessment of the IPSS-M in Chronic Myelomonocytic Leukemia. (#3205)

Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q))

Montoro MJ, Palomo L, Haferlach C, Acha P, Chan O, Navarro V, Kubota Y, Schulz F, Briski R, Al Ali NH, Xicoy B, Lopez F, Bosch F, Meggendorfer M, PhD12, González T, Eder LN, Jerez A, Wang YH, Campagna A, Santini V, Bernal T, Such E, Tien HF, Kubasch AS, Díaz Varela N, Platzbecker U, Haase D, Diez-Campelo M, Della Porta MG, Garcia-Manero G, Wiseman DH, Germing U, Maciejewski J, Komrokji RS, Sole F, Haferlach T, Valcarcel D. Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q)). (#666)

Parallel Sequencing of Transposons and Transcriptomes in Single Cells for Genome-Wide Cancer Gene Discovery

Holz M, Klinger B, Stuckenbrok F, Bamopoulos SA, Gosavi S, Bräuning C, Altmüller J, Rad R, Haferlach T, Blüthgen N, Keller U, Conrad T, Baumgartner F. Parallel Sequencing of Transposons and Transcriptomes in Single Cells for Genome-Wide Cancer Gene Discovery. (#1351)

Telomere Content Diversity in Myeloid Neoplasia Could Inform on Differential Sensitivity to Telomerase Inhibitors

Guarnera L, Wahida A, Gurnari C, Hutter S, Stainczyk, Williams ND, Durmaz A, Kubota Y, Bravo-Perez C, Kawashima N, Pagliuca S, Yimin Huang, Laframboise T, PhD11*, Valeria Visconte V, Walter W, Meggendorfer M, Haferlach C, Kern W, Westermann, Feuerbach L, PhD, MSc, BSc15*, Torsten Haferlach, Maciejewski. Telomere Content Diversity in Myeloid Neoplasia Could Inform on Differential Sensitivity to Telomerase Inhibitors. (#4104)

A Unified Post-Transcriptional Mechanism Regulates Intron Retention in Splicing Factor-Mutant MDS

Boddu P, Roy R, Baumgartner F, Hutter S, Haferlach T, Pillai M. A Unified Post-Transcriptional Mechanism Regulates Intron Retention in Splicing Factor-Mutant MDS. (#2732)

Single-Cell Multiomics Unveils Venetoclax-Resistant Monocytic Differentiation and Immune Evasion in TP53 Mutant AML Clones

Ayoub E, Lehotzky D, Li L, MD, Muftuoglu M, Nishida Y, Mohanty V, Leighton JS, Patsilevas, Basyal M, Bedoy A, Haferlach T, Takahashi K, Chen K, PhD3*, Navin N, Issa GC, Gad Getz G, Andreeff M. Single-Cell Multiomics Unveils Venetoclax-Resistant Monocytic Differentiation and Immune Evasion in TP53 Mutant AML Clones. (#61)

Donations

You wish to support the foundation’s work? Our donation account is:

HypoVereinsbank

IBAN: DE9374 3200 7300 2778 2329
BIC/SWIFT: HYVEDEMM433

Purpose of payment line 1:
THLDS

Purpose of payment line 2:
Address of donor

Contact

We will gladly answer your questions or provide you with information on the Foundation.

Telephone +49 (0)89 99015-0       Send an e-mail